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ABSTRACT 
THE EFFECTS OF PERCEIVED RISK AND RESPONSIBILITY ON THE 
ACCEPTANCE OF A HUMAN PAPILLOMAVIRUS VACCINE BY COLLEGE MEN 
by 
Angela Marie Mitiguy 
University of New Hampshire, September, 2009 
In the summer of 2006 the Food and Drug Administration approved a new 
vaccine to prevent four types of the Human Papillomavirus believed to cause the majority 
of genital warts and cervical cancer in women. Since that time the vaccine has 
experienced considerable uptake among women while it has also been met by some 
criticism. Current medical research aims to understand if the vaccine, which has been 
approved only for women, could be used to prevent HPV in men. 
Little empirical research has been conducted to understand whether or not men 
would be willing to receive a vaccine for a sexually transmitted infection that poses few 
serious health risks for them. This research investigates the level of acceptance among a 
sample of males at a large public university in New Hampshire as well as some of the 
possible predictors of men's acceptance of a Human Papillomavirus vaccine. 
Specifically, men's perceived risk for contracting the virus and its possible health 
consequences and their perceived sense of responsibility for sexual behavior will be 
examined as predictors of vaccine acceptance. 
INTRODUCTION 
In the summer of 2006 a new vaccine was approved by the Food and Drug 
Administration to prevent the spread of certain strands of the Human Papillomavirus 
(HPV) in women (http://www.cdc.gov/vaccines/vpd-vac/hpv/hpv-vacsafe-effic.htm, 
2007). HPV is the most commonly spread sexually transmitted infection in the United 
States and the cause of several types of cervical cancer 
(http://www.cdc.gov/std/HPV/STDFact-HPV.htm, 2008, Goldstein, 2008). Just over two 
years after its initial introduction medical research is now examining the possibility of a 
vaccine aimed at preventing HPV in men (http://www.cdc.gov/vaccines/vpd-
vac/hpv/hpv-vacsafe-effic.htm, 2007). While the female vaccine has experienced 
considerable uptake, it is important to understand whether or not men would be willing to 
accept and receive this vaccine after nearly two years of the vaccine being marketed 
mainly as a cervical cancer prevention vaccine. How will men's perception of their own 
risk for contracting HPV and their views on sexual behavior responsibility impact their 
decision to receive the vaccine if one ever becomes available for them? 
This study aims to investigate the effect of men's perceptions surrounding risk 
and responsibility on the acceptance of a male HPV vaccine. While previous research has 
examined the factors surroundings parents' decision making in regards to vaccinating 
their children (e.g. Brabin et al., 2006, Marlow et al., 2007) and men and women's 
willingness to vaccinate (Jones and Cook, 2008), no known prior research has looked 
specifically at the effects of perceived risk and responsibility on men's acceptance of a 
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male HPV vaccine. This study also aims to understand the effects, if any, of men's 
exposure to the current Gardasil1 marketing campaign on their understanding of HPV and 
their willingness to receive a vaccine. 
This report will begin with a review of the literature surrounding sexual behavior 
responsibility regarding contraceptive use and unwanted pregnancy as a theoretical 
structure to frame the current HPV vaccine situation. I will then review the current 
research that is available on the Human Papillomavirus vaccine in regards to attitudes 
about the vaccine and willingness to vaccinate either one's self or one's child. This will 
include literature regarding the effects of level of knowledge about the virus and vaccine, 
demographic factors, and gender. 
Overall Contribution 
There are gender differences when it comes to expectations in sexual 
responsibility. Previous research has looked at the social processes that have created an 
environment in which women are primarily responsible for contraceptive use and are 
expected to be the responsible partner in a sexual relationship (e.g. Oudshoorn, 2003). 
With new advancements in medical technologies to combat one of the most common 
sexually transmitted infections it is important to understand how these social 
constructions might affect the uptake of HPV vaccines by both sexes. The medical field 
and vaccine technologies in particular are continually growing and changing and it is 
important for Medical Sociology to continue to grow with and understand the social 
1
 Gardasil is the leading Human Papillomavirus vaccine currently available for women. It is manufactured 
and marketed by Merck & Co. More information about the Gardasil vaccine and the marketing campaign 
around it will be presented in chapter II. 
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implications of these technologies on men and women and the social factors that 
influence how they are accepted and used by society. 
Practical Implications 
The Human Papillomavirus is one of the most prevalent sexually transmitted 
infections and has become the center of a great deal of medical research. Companies have 
already begun marketing and producing a vaccine to prevent HPV in women but women 
are not the only people to contract HPV. The Human Papillomavirus is not purely a 
women's health issue. Men do contract the virus and there are medical consequences 
associated with HPV for them as well. Currently, medical research is investigating the 
possibility of a vaccine that would prevent HPV in men. This study could help inform 
researchers as to whether or not men would be willing to receive an HPV vaccine or 




The Human Papillomavirus 
The Human Papillomavirus (HPV) is a common infection that is passed on 
through genital contact, usually through vaginal or anal sex. Most individuals are not 
aware they have HPV because many times it does not carry any symptoms. There are an 
estimated 40 different strands of HPV, with some types causing genital warts in both 
males and females and other types causing up to 95% of cervical cancer cases. HPV is 
the most common sexually transmitted infection in the United States, with approximately 
20 million Americans currently infected and an additional 6.2 million people contracting 
the infection annually. Approximately 50% of sexually active men and women will 
acquire an HPV infection at some point in their lifetime. HPV is most common among 
people in their late teens and twenties. High-risk HPV has the ability to transform normal 
cells into abnormal cells, which can result in more serious medical complications. Most 
of the time the body will fight off the infection on its own and the virus will clear within 
two years (http://www.cdc.gov/std/HPV/STDFact-HPV.htm, 2008). HPV does have 
specific health consequences for men and women although women are at a greater risk 
for both contracting the virus and developing more serious health issues. 
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The Human Papillomavirus and Women. Certain strands of HPV and persistent 
cases of the virus have the ability to cause cervical cancer in women. In high-risk cases a 
woman can have HPV for many years during which time those abnormal virus cells may 
become cancerous. Approximately 10% of women who have high-risk HPV on their 
cervix will develop persistent HPV infections which could put them at risk for cervical 
cancer. Researchers suggest that up to 95% of all cervical cancer cases in the United 
States are caused by these strands of HPV. The American Cancer Society estimated that 
11,070 women would be diagnosed with cervical cancer in 2008. Unfortunately, cervical 
cancer does not usually present any symptoms until it is has reached an advanced stage so 
it is extremely important for women to undergo regular cervical cancer screenings 
(http://www.cdc.gov/std/HPV/STDFact-HPV.htm, 2008). Clearly, HPV poses a serious 
health risk to women. 
The Human Papillomavirus and Men. While men contract the Human 
Papillomavirus, they are less likely to get the virus than women are. Few men will know 
that they actually have the infection as it usually does not present any symptoms. There 
are some complications that result from certain strands of HPV in men, including genital 
warts, and penile and anal cancers. The rates of these cancers are significantly lower than 
the rates of cancer in women; therefore, HPV does not pose as much of a risk to men as it 
does to women. Penile cancer only affects 1 in every 100,000 men in the United States. 
The American Cancer Society estimates that 1,250 men will be diagnosed with penile and 
other male genital cancers in 2008. Only about 1% of sexually active men in the United 
States will have genital warts at any one time. Currently there is no way to test for the 
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virus in men nor is there a vaccine like there is for women. Research is investigating the 
possibility of using the current vaccine for men or of developing a vaccine specifically 
for male use (http://www.cdc.gov/std/HPV/STDFact-HPV.htm, 2008). 
The Human Papillomavirus Vaccine 
Presently, there is a vaccine available for women which prevents four types of 
HPV, types 6, 11, 16, and 18, that cause most cervical cancer and genital warts 
(http://www.gardasil.eom/what-is-gardasil/information-on-gardasil/index.html#nine, 
2008). The vaccine is recommended for girls who are between 11 and 12 years old and is 
available for women through 26 years of age who have not yet had the vaccine or 
completed the three shot series. It is recommended that girls receive the vaccine before 
becoming sexually active because the vaccine works best for women who have not yet 
encountered any of the strands of HPV and does not work as well for women who have 
been exposed to the infection before getting the vaccine 
(http://www.cdc.gov/std/HPV/STDFact-HPV.htm, 2008). Currently, there is no approved 
vaccine for men, although research is examining the possibility of a vaccine to prevent 
HPV in men or if the female vaccine will be effective in men. 
Breakdown by Demographic Characteristics 
Research has looked at the acceptance of the HPV vaccine among different socio-
demographic groups. Brabin et al. (2006) found that socio-demographic characteristics 
made no difference between those parents who approved of the vaccine for their children 
and those who did not. Ethnicity and age of respondent were not statistically associated 
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with vaccine acceptance (Brabin et al., 2006). Lenselink et al. (2008) found that gender 
and age were statistically related to vaccine acceptance among young adults, with women 
and younger participants being more willing to vaccinate themselves against HPV. In a 
study of mothers in England, Marlow et al. (2007) found that demographic characteristics 
such as mother's level of education, ethnic background, employment and marital status 
did not affect their acceptance of the vaccine. Age of respondent and relationship status 
will be used in the current study as demographic variables. 
Knowledge about the HPV Vaccine 
Previous research on the HPV vaccine has aimed to investigate whether or not the 
amount of knowledge a person has about the vaccine will affect their decision to have 
their child receive it. Dempsey et al. (2006) found that when participants were provided 
with a fact sheet containing information about HPV and its vaccine they scored higher on 
a HPV assessment. The increased knowledge provided by the HPV information sheet did 
not increase the likelihood that participants would accept the vaccine (Dempsey et al, 
2006). Lenselink et al. (2007) also found that increased knowledge about HPV and 
cervical cancer would not mean increased acceptance of the vaccine and that overall 
about 88% of their sample would accept the vaccine regardless of differences in several 
independent variables, including level of education and marital status. This raises the 
question of whether or not the 88% acceptance is the result of all of the effort to publicize 
the vaccine. In a more recent study Lenselink et al. (2008) found that knowledge of HPV, 
and knowledge of cervical cancer were not statistically associated with young Dutch 
adults' acceptance of a Human Papillomavirus vaccine. 
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Perception of Sexual Behavior Responsibility 
Previous research has examined the relationship between gender and sexual 
behavior responsibility. Grady et al. (1996) found that men were more than twice as 
likely to say that they believed men held the majority of responsibility in contraceptive 
decision making as they were to say that women did. If men believe that they are to be 
the partner responsible for contraceptive decision making then perhaps this will extend to 
their decision making for vaccine prevention. Therefore, men who believe that men hold 
the majority of sexual behavior responsibility will be more willing to vaccinate compared 
to those who believe that sexual responsibility should be a woman's concern. 
Other research has examined a similar development in the medical field in which 
medical technology investigated the development of male hormonal contraceptive pill 
and while this pill was easily developed in the lab there were several social hurdles that 
made it unsuccessful in practice (Oudshoorn, 2003). Oudshoorn (2003) suggests that one 
of these hurdles was including men as responsible partners in family planning practices. 
Previously men had not been included in the discourse on family planning and 
contraceptive use was seen primarily as a woman's responsibility (Oudshoorn, 2003). 
While it seems that medical research may be able to develop the male HPV vaccine fairly 
quickly this does not assure that society will be ready and will to accept it and that men 
will be willing to vaccinate. 
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Perception of Risk 
Jones and Cook (2008) conducted a study that addressed university men and 
women's intentions to receive an HPV vaccine. This study found that among college age 
men and women both groups reported a high intent to receive the vaccine. Men were 
more likely to report an intention to receive the vaccine if the vaccine would prevent 
genital warts and cervical cancer then they would be if the vaccine only prevented 
cervical cancer (Jones and Cook, 2008). Boehner et al. (2003) also found that one of the 
predictors of college students' acceptance of a Human Papillomavirus vaccine was 
whether or not students had numerous sexual partners, suggesting that the higher 
students' perception of risk for contracting the disease, the more likely they would be 
willing to accept a vaccine to prevent infections. Like Jones and Cook (2008), this study 
also found an overall high vaccinate acceptance (approximately 74%) for a Human 
Papillomavirus vaccine and a genital herpes vaccine (Boehner et al., 2003). 
These studies were conducted before the vaccine to prevent HPV in women 
became available in the summer of 2006. In November of 2006 Merck & Co., the 
creators of Gardasil, launched a comprehensive print, television and online campaign to 
market the vaccine to girls and women, age 9 to 26. The campaign's slogan, "One Less," 
is aimed at encouraging women to be "one less" woman who will have to battle cervical 
cancer. Since then there have been two years of marketing the vaccine as a cervical 
cancer prevention, with less attention being paid to genital warts or other complications. 
Would men be less likely to intend to receive the vaccine now that they have been 
exposed to these commercials which describe HPV as a primarily female health problem? 
This study aimed to explore the effects of this campaign on vaccine decision making. 
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Gaps in the Literature 
While the previous research on the Human Papillomavirus and the vaccine has 
targeted parental intention to vaccinate children and looked at basic socio-demographic 
differences in regards to decision making, very little has investigated the response men 
might have to the vaccine and the factors that may affect their decision making. This 
study aims to fill this gap in the literature and hopefully inform researchers of the 
possible uptake of a male vaccine if one becomes available. This study works as an 
acceptability study aimed at understanding whether or not a new population will welcome 
a new technology and hopefully informing the direction this line of medical research 
should take in the future. Acceptability was defined by Marshall in 1977 as "a quality 
which makes an object, person, event, or idea pleasing or welcome" (Marshall, 1977: 65). 
The overall goal of this project is to fill a gap in the current HPV vaccine literature by 
adding men's acceptance of an HPV vaccine to the information that is presently 
available. 
While previous research has focused on knowledge of the virus and vaccine as 
predictors of acceptance, this study will focus on the effects of perceived risk and 
responsibility, largely socially constructed, that may affect uptake. It is hypothesized that 
men's beliefs surrounding their level of risk for contracting the Human Papillomavirus 
and the medical consequences associated with it will be the result of how society has 
presented information on this relatively new health topic instead of being based on actual 
medical facts. This could be the result of current marketing campaigns for the women's 
vaccine as well as the present discussion that surrounds HPV. 
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In a similar manner the level of responsibility that men feel they should take in 
protecting themselves against the Human Papillomavirus may not be an accurate 
reflection of this level of risk. For example, because HPV is prevalent among men and 
has serious medical complications they should be interested in protecting themselves 
against the virus, but perhaps their level of responsibility instead reflects whether or not 
society has encouraged them to take responsibility for their sexual behavior and the 
consequences associated with it. As a basis for this idea, a book by Nelly Oudshoorn 
(2003) will be used. This work, in part, looks at the effect that male responsibility had on 
the development of a male contraceptive pill. These two medical technologies, a male 
contraceptive pill and a male HPV vaccine, raise parallel issues because of the effects 
which both topics, unwanted pregnancy and HPV, have on women compared to men. 
This study can be seen as an extension of Oudshoorn's work as it addresses one of the 
current advancements in biomedical research which differentiates men and women. 
In response to the gaps in the current literature that have been outlined above, I 
have investigated the following hypotheses: 
Hypotheses 
Hypothesis I. Men who report a greater perceived risk for contracting HPV and 
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Hypothesis III. Men who report having been exposed to the current Gardasil commercials 
for HPV will be more likely to reject getting the vaccine. This could be a result of the fact 
that men who have been exposed to Merck's marketing campaign will view HPV as more 
of a women's health issue and the vaccine as more of a cervical cancer prevention 
vaccine instead of a sexually transmitted infection prevention. This relationship will be 
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This research will draw on the area of sexual responsibility research to create a 
framework in which one can understand men's relationship to the Human Papillomavirus 
and the vaccine. Primarily, research looking at men's views of contraception 
responsibility will be used to establish how men view contraceptive use and who they 
feel should take control of preventing unwanted pregnancy as well as contracting other 
sexually transmitted infections. Specifically, research on preventing and contracting HIV 
will be used as an example of this. 
Some similarities can be established between gendered experiences of HPV and 
unwanted pregnancy that rationalize the use of this research for the current study. 
Because men are not directly affected by unwanted pregnancy, compared to women, they 
may feel that women should take more responsibility for preventing pregnancy. The same 
similarities can be seen with the Human Papillomavirus, because women experience 
more negative consequences from the virus, men may feel that HPV is more of a 
women's sexual health issue and therefore it is more their responsibility to protect against 
contracting the virus. Similarities can also be seen between HPV and HIV because 
women can contract both infections easier than men can. A woman is much more likely 
to contract HIV during vaginal intercourse than a man is (Padian, Shiboski, and Jewell, 
1991). The Human Papillomavirus is also more easily transmitted from a man to a 
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woman than from a woman to a man during sexual intercourse 
(http://www.cdc.gov/std/HPV/STDFact-HPV.htm, 2008). 
This study will explore the effect of gender socialization on vaccine acceptance 
among college age men, specifically looking at their perception of risk and sexual 
behavior responsibility. These perceptions may be the result of larger socialization 
patterns that have tended to place a heavier burden of responsibility for sexual behavior 
on women then on men and the result of a marketing campaign that promotes HPV 
primarily as a woman's sexual health issue. If men see their risk for infection and sense 
of responsibility as being low then they will be less accepting of an HPV vaccine to 
prevent the infection in men. Lower levels of perceived risk may be associated with 
exposure to current HPV vaccine commercials that present it as a cervical cancer 
prevention tool. 
Nelly Oudshoorn's book, The Male Pill (2003), examines the challenges 
surrounding the attempt to introduce a hormonal contraceptive pill for male use, even 
though one had easily been developed scientifically. Oudshoorn (2003) suggests that the 
acceptance of a contraceptive pill for men relies heavily on a shift in attitudes 
surrounding reproductive responsibility. The obstacles do not lie in the scientific field but 
rather in the cultural (Oudshoorn, 2003). 
An important strategy in the advocacy of male involvement in family 
planning has thus consisted of counteracting the dominant cultural 
narratives on men and family planning. This was only a first step in 
changing family planning discourse toward the inclusion of men. Another 
equally, or maybe even more, important part of the cultural work of men 
and family planning advocates consisted of changing the objectives and 
vocabulary of family planning (Oudshoorn, 2003: 123). 
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Oudshoorn's work is an important resource for this study because it relates very 
closely to this paper's topic. She suggests that the development of the family planning 
industry focused mainly on women and the use of female contraceptive pills because the 
medical field had a long history of viewing sex and reproduction as closer to the nature of 
women than to the nature of men and this "natural" connection made women an obvious 
subject of special research in the medical field (Oudshoorn, 2003). Because female 
bodies were seen as being naturally closer to reproduction, the medical community 
suggested that it was "more natural" and easier to interrupt the process of ovulation than 
to disrupt the production of sperm cell (Oudshoorn, 2003). With a strong focus on women 
and a belief that women are somehow more closely connected to reproduction, men have 
largely been left out of the discourse on family planning and sexual behavior 
responsibility that has emerged out of the medical community. It seems logical that this 
disregard for male participation in family planning may extend to their involvement in 
sexually transmitted infection prevention. 
Oudshoorn (2003) suggests that we can use contraceptive technologies for 
understanding how certain forms of gender gain cultural dominance in society while 
other forms remain largely marginalized. The view that women's bodies are at the center 
of sex makes them the focus of discussion and research and leaves men detached and 
unaccounted for. Oudshoorn (2003) writes that "the predominance of contraceptives for 
women contributed to a stabilization of performances of gender, which constituted a 
strong alignment between femininity and contraceptive use" (Oudshoorn, 2003:16). This 
view has dominated for several decades and has shaped how we view gender differences 
in sexual behavior responsibility. 
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The results of this research could have possible theoretical and practical 
implications for the field of sociology and the understanding of the uptake of new 
medical technologies. In regards to sociology this study would contribute largely to the 
area of a medical sociology as well as to the area of gender. This research also has 
practical implications for the introduction and acceptance of new medical information 
and may inform medical researchers about the direction they should be taking in 
furthering the prevention of HPV. Male acceptance of this vaccine could also provide 
important insight into their acceptance of possible future vaccines for other diseases, such 





The goal of this research is to understand college men's acceptance of a Human 
Papillomavirus vaccine and factors that may predict variation in acceptance. The research 
design for this study is a cross-sectional survey design. A questionnaire was administered 
aimed at addressing the three main hypothesis discussed earlier, mainly participants' 
perceived risk of getting HPV and the complications associated with the infection, their 
sense of responsibility for sexual health and sexual responsibility and their exposure to 
current HPV vaccine advertisements. This last set of questions addressed whether or not 
participants have seen any of the HPV vaccine advertisements currently running in order 
to assess their effect on acceptance of a male vaccine. All statistical analyses were 
conducted using the computer program, Stata. 
Sample 
The sample for this study is college age men. Participants were recruited from a 
large state university in a northeastern state. These participants were enrolled in general 
education classes at the time of this study in an attempt to gain a representative sample of 
the college population. Classes were randomly sampled from each of the nine sections of 
general education courses at the university by assigning each course a number and then 
randomly drawing classes from each section. The professor for each course was 
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contacted via an e-mail which explained the nature of the study and asked for their 
assistance in recruiting male participants from their course. A copy of the recruitment 
letter that was sent to professors can be found in Appendix A at the end of this report. If 
professors declined to participate then additional courses within the same section were 
sampled so that there was representation from all nine of the types of general education 
classes. The goal sample size was approximately 200. 
Unfortunately, there was difficultly establishing the size of the sample that was 
originally desired. While the sampling technique was sound, there was an overall 
unwillingness of college professors to extend the survey to their male students. After 
several rounds of sampling and contacting professors the study yielded approximately 80 
male participants. There is an overall difficulty in getting this particular demographic 
group to respond to survey questionnaires. It could be that individuals in this 
demographic are unwilling to participant in social science research in general or that the 
use of the internet survey was not successful with this particular group because it required 
participants to go to the survey on their own. The response rate may have been higher if 
surveys were administered in class but it seems like it may have been difficult to collect 
data this way because of the difficulty in gaining assistance from some professors. Future 
attempts to gain access to this population may be more successful if there were more 
resources available and more desirable incentives for participants. 
Measures 
The measures for this study were included in the questionnaire which was sent to 
the participants using the online survey provider Survey Monkey. The survey began with 
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several questions aimed at addressing certain demographic characteristics of the sample. 
Other parts of the survey included scales with items aimed at creating measures of 
perceived risk, perceived sexual behavior responsibility, and the effects of HPV vaccine 
advertising. Each of the measurements will be described in detail below. All measures 
can be found in Appendix B at the end of this report. 
Independent Variables 
Perception of Risk The first independent variable was participants' perceptions of 
their risk of contracting the Human Papillomavirus and the risk of developing possible 
complications associated with the infection. This variable was measured by asking 
participants to express how real they feel the possibility is for them to contract HPV, how 
important of an issue they feel HPV is, and whether or not they feel they feel at risk for 
the infection. Responses were provided by giving level of agreement on a Likert scale 
with low responses corresponding to low levels of perceived risk and high response 
corresponding to higher perceived risk. 
Perception of Responsibility. The second independent variable was participants' 
perceptions of sexual responsibility. Items aimed to address who participants feel is most 
responsible for contraception, themselves or a possible sexual partner, and who should be 
responsible for dealing with unplanned pregnancies, men or women. This section of items 
aimed to understand whether or not beliefs about sexual behavior responsibility and 
contraception use can extend to a willingness to protect against sexually transmitted 
infections by receiving a vaccine. The items used to address participants' sexual behavior 
20 
responsibility come from The Gender-Equitable Men Scale (GEM Scale) created by 
Pulerwitz and Barker (2007). 
Exposure to HPV Vaccine Advertisements. In the summer of 2006 a vaccine was 
introduced to prevent HPV in women, specifically two types most commonly associated 
with causing cervical cancer and two other types thought to cause genital warts. In order 
to promote the vaccine several advertisements have been created aimed at encouraging 
young women and mothers to get the vaccine for themselves or their daughters. These 
commercials largely describe the vaccine as a prevention for cervical cancer. The 
question becomes, will men be less inclined to think that HPV is a sexually transmitted 
infection that affects men if they have been exposed to commercials that promotes it 
primarily as a women's health issue? The final section of this survey asked participants to 
provide information regarding their exposure to the current HPV vaccine campaign as 
well as a few open-ended questions which aimed to understand what effects, if any, these 
advertisements have on their understanding of HPV and current prevention strategies. 
Control Variables 
The following variables were used as control variables during the analysis of this 
data: age, residency, and relationship status. Age was categorized as 18 years old, 19 
years old, 20 years old, 21 years old, 22 years old, and 23 and older. Residency asked 
students whether they are in-state students or out-of-state students. Finally, relationship 
status asked respondents to categorize their current status as either single, casually dating, 
in a serious relationship, cohabitating with a partner, or married. 
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Dependent Variable 
Decision to Receive the Vaccine. In order to assess whether or not respondents 
would accept a possible male HPV vaccine, they were asked whether or not they would 
personally receive the vaccine if one ever became available. The respondents were asked 
to disregard the cost of the vaccine or whether or not their insurance would cover the cost 
when making a decision about their willingness to vaccinate. This was because I wanted 
to understand how participants felt about the importance of vaccinating themselves 
regardless of the effects of financial constraints. 
Mediating Variable 
Perception of Risk. The level of risk participants perceive they are at for 
contracting HPV can also be a mediating variable between their exposure to HPV vaccine 
advertisements and their decision to receive the vaccine. It is possible that viewing these 
advertisements may reduce participants' perceived risk because they portray HPV as a 
predominately female health issue, resulting in men thinking that it is purely a women's 
health issue and not something that they are at risk for and should be concerned with. 
Procedure 
After a list of nine general education courses were sampled and participation was 
approved by the instructors of the courses, the survey link was e-mailed to professors so 
that it could be offered to their male students either through e-mail or through their 
course website. Participants could then access the survey when and wherever they wanted 
and complete the five minute questionnaire. Participants were also given the opportunity 
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to enter their names in a raffle for a chance to win a gift certificate to a local electronics 
store. 
Limitations of the Methodology 
The largest limitation to the current study is the ability to generalize the findings 
to a larger population of men. This is because the sample is from a large university in a 
predominately white northeastern state and is not representative of the national 
population. Another limitation surrounds the effects of exposure to Human 
Papillomavirus advertisements on acceptance of male vaccine. It is impossible to fully 
understand the extent of this effect without conducting an experiment in a laboratory 
setting with a control group. The best that can be done is to rely on participants' reports 
of their experiences with these advertisements. 
Another possible limitation to this study which relates to the sample is the issue of 
response bias. It could be, and quite possibly is, that those male college students who 
chose to participate in a study regarding a sexually transmitted infection are different 
from those male college students who chose not to participate. This possible difference 
could be a major limitation to this study and to understanding what the male college 
population really believes about protecting about the Human Papillomavirus and what 
their future behavior would be regarding their decision to vaccinate if a vaccine does 
become available for them. Instead of understanding the male college population as a 
whole, this study may only address the beliefs of a specific type of male college student. 
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Human Subjects Research 
This research used human subjects for data collection so it was imperative that all 
steps were taken to ensure that no harm would come to participants. This study was 
approved by the Institutional Review Board at the University of New Hampshire. A copy 
of the letter of approval from the Institutional Review Board can be found in Appendix E. 
Protection of Human Subjects. In order to fully protect all study participants there 
were certain procedures taken to ensure participants' consent, safety and privacy. 
Appendix B provides an example of the consent form that participants had to read and 
agree to before they completed the survey. The consent form explained that all the 
information provided would remain confidential and that the participants would remain 
anonymous in any work that resulted from this research. Respondents' names were in no 
way associated with the information they provided in the survey. 
Although there were no immediate risk to participants the questions that were 
asked may have raised some levels of anxiety as some deal with sexual promiscuity and 
sexually transmitted infections. A list of resources, including those that can provide more 
information about sexually transmitted infections and those that provide further 
information about the Human Papillomavirus and the current vaccine, were be provided 
to participants at the end of the survey. The list of resources provided to participants can 
be found in Appendix D at the end of this report. Respondents were informed that the 
greatest benefit of participating in this study was the contribution that they were able to 
make to a larger body of knowledge. Another possible benefit to participating in this 
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study was the opportunity to participate in a raffle drawing and the possibility of winning 




The data collected for this study was analyzed using the statistical computer 
program, Stata. This chapter will begin with a section of descriptive statistics, which will 
aim to illustrate the group of college men which constitute this particular sample. Tables 
will then be presented that examine the relationship between the items addressing sexual 
behavior responsibility and perceived risk for the Human Papillomavirus and 
respondents' age and relationship status. This will be done to examine if there is a 
relationship between the age or current relationship status of participants and their 
agreement with each of the statements found under these two categories of sexual 
behavior responsibility and perceived risk. 
I will then examine the effects of perceived sexual behavior responsibility on 
vaccine acceptance by looking at the items aimed at addressing their beliefs surrounding 
contraceptive use and handling unwanted pregnancy. The next section will evaluate the 
relationship between vaccine acceptance and perceived risk for the virus. The purpose of 
these two analyses is to determine if one's views on sexual behavior responsibility and 
their perception of risk for HPV will influence their willingness to vaccinate against the 
infection. Basic cross-tabulations and chi-square tests were conducted to examine the 
significance between the items for sexual behavior responsibility and perceived risk for 
HPV and the population as well as the population's willingness to vaccinate. Finally, I 
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will address the effects of exposure to the current Gardasil campaign on vaccine 
acceptance, including participants' open-ended responses, which have been categorized 
and presented in a table. 
Descriptive Statistics 
Table 1. Summary statistics 
Variable 









In a serious relationship 
Cohabitating 
Married 
Willingness to vaccinate 
Very willing 
Somewhat willing 

































A summary of the descriptive statistics for this population can be found in Table 
1. Seventy-nine undergraduate male students from a large state university in a North 
Eastern state responded to the internet survey that was available on Survey Monkey. Of 
these 79 respondents only 68 actually completed the entire survey. Participants' ages 
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ranged from 18 to 23 years old with the average age being 19.5 years. Age was collapsed 
and categorized as those who reported being 18 or 19 and those who were 20 or older. 
Approximately 52% of the respondents were 18 or 19 years old and 48% were 20 years 
old or older. These two categories of age will be used when the variable age is used in 
any further statistical analyses. 
One of the first questions on the survey addressed whether respondents are in-
state students or out-of-state students. In this sample, approximately 64% of respondents 
reported being in-state students and 36% reported being out-of-state students. This 
question was asked in order to establish what percentage of the sample was from the 
small northeastern state where the university was located. If a large percentage of the 
population reported being from this state then it may affect the results as the sample may 
not be as representative of this demographic. 
The beginning of the survey also asked participants to express what their current 
relationship status would be. Seventy-three percent of respondents claimed to currently 
be either single or casually dating, while 25% claimed to be in a serious relationship. The 
other 2% of respondents were either married or cohabitating with a partner. This two 
percent was dropped from consideration during analysis because it represented such a 
small percentage of the sample and was only a few participants. The other categories 
were also collapsed so that those respondents who were currently single could be 
compared to those who were in exclusive relationships. In order to do this, those who 
reported either being single or casually dating were collapsed into one category which 
from now one will be considered single. This category was compared to those who 
reported being in a serious relationship. 
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Vaccine Acceptance 
The central item from this survey was whether or not individuals would be willing 
to receive an HPV vaccine if one ever became available. Participants were asked to 
disregard cost or insurance coverage when responding to this item. Sixty-two percent of 
the participants reported being willing to receive a vaccine, only 7% reported being 
completely unwilling to vaccinate, and the remaining 31% of participants reported being 
neither willing nor unwilling to receive a vaccine. For statistical purposes this 31% was 
collapsed with those who reported being unwilling. The goal of this analysis is to 
examine what is different between those individuals who would be willing to vaccinate 
from everyone else. Those respondents who reported feeling neutral about their decision 
to vaccinate and those who would choose not to vaccinate were collapsed together 
because of the small sample size. It was also important to this study to be able to establish 
characteristics and attitudes of those who would definitely be willing to vaccinate against 
the HPV vaccine from those who are not. The responses for this question can also be 
found in Table 1. 
Sexual Behavior Responsibility 
Each of the seven items in the section of the survey dealing with sexual behavior 
responsibility were compared to respondents' age and relationship status and chi-square 
tests were conducted to determine if there was a relationship between any of these items 
with the age or relationship status of a respondents. 
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Table 2. Chi-square of Sexual Behavior Responsibility by Age and Relationship Status 
Sexual Behavior Responsibility 
It is the man who decides what type 
of sex to have. 
Agree 
Disagree 
It is a woman's responsibility to 
avoid getting pregnant. 
Agree 
Disagree 
I would be outraged if my sexual 
partner asked me to use a condom. 
Agree 
Disagree 
A couple should decide together if 
they want to have children. 
Agree 
Disagree 
In my opinion, a woman can 




If a guy gets a woman pregnant, the 
child is the responsibility of both. 
Agree 
Disagree 
A man and a woman should decide 





























































































In Table 2, I present the results of the cross-tabulations and chi-square tests for 
sexual responsibility against age and relationship status. The table presents the 
percentages of those respondents who agreed and disagreed with the provided statements 
based on their age and their relationship status. In order to compare these variables the 
original categories for agreement were collapsed. The original categories "agree" and 
"somewhat agree" were combined together and were compared to those individuals who 
responded that they disagreed with the statement. None of these seven items under sexual 
behavior responsibility were statistically related to either the respondents' age or their 
reported relationship status. The first item on this list asked for respondents' agreement 
with the following statement: "It is the man who decides what type of sex to have." 
Almost 62% of 18 or 19 years old agreed with this statement, compared to approximately 
38% who disagreed. When comparing this group with the other age group, approximately 
46% of those 20 years and older agreed with this statement, while 54% of those 20 and 
older disagreed with it. 
Another item from the sexual behavior responsibility section that was compared 
with age and relationship status was the relationship between with the third statement in 
this section, "I would be outraged if my sexual partner asked me to use a condom," and 
relationship status. Of those who reported being in an exclusive relationship, 
approximately 89% disagreed with this statement compared with about 11% who agreed 
with this statement. For those respondents who reported currently being single only 2% 
agreed with this statement and approximately 98% disagreed. 
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Perceptions of Risk 
Table 3. Chi-square of Perceived Risk for Contracting HPV with Age and Relationship 
Status 
Perceived HPV Risk 
Men are just as likely to contract 




The medical complications of 
HPV are just as severe for men 
as they are for women. 
Agree 
Disagree 
HPV is the leading cause of 
penile and anal cancers in men. 
Agree 
Disagree 
It is just as important for men to 
protect themselves against HPV 






























































In Table 3, I present the results of a second cross-tabulation and chi-square tests 
comparing respondents' agreement with certain items addressing perceived risk for the 
Human Papillomavirus and respondents' age and relationship status. Again, similar to the 
statements addressing sexual behavior responsibility, none of the items addressing 
perceived risk for HPV were statistically related to either respondents' age or their 
relationship status. Agreement with the first item, "Men are just as likely to contract the 
Human Papillomavirus as women," is not statistically related to respondents' relationship 
status. Of respondents who reported being single 62% agreed with this statement 
compared with 38% of single respondents who disagreed with this statement. The 
percentages for agreement were almost exactly the same for those respondents who 
reported currently being in an exclusive relationship. Approximately 62% agreed with 
this statement while approximately 38% disagreed. There is no difference in relationship 
status between those who agreed with this statement and those who disagreed with it. 
When compared to age, responses of agreement and disagreement were evenly split 
between the two age categories identified earlier. There does not seem to be a pattern to 
agreement or disagreement with these items and this could be because respondents do not 
know a lot about the Human Papillomavirus and their perceptions of risk are not based on 
actual knowledge. 
Willingness to Vaccinate 
Cross-tabulations were also conducted with these sets of items regarding sexual 
behavior responsibility and perception of risk for the Human Papillomavirus and 
participants' responses to the question regarding willingness to vaccinate to determine if 
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there is a relationship between respondents' views on sexual behavior responsibility and 
perceived risk for contracting the Human Papillomavirus and their willingness to protect 
themselves if a male HPV vaccine ever becomes available. 
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Table 4. Chi-square of Sexual Behavior Responsibility and Willingness to Vaccinate 
Willingness to Vaccinate 
Sexual Behavior Responsibility 
It is the man who decides what type 
of sex to have. 
Agree 
Disagree 
It is a woman's responsibility to 
avoid getting pregnant. 
Agree 
Disagree 
I would be outraged if my sexual 
partner asked me to use a condom. 
Agree 
Disagree 
A couple should decide together if 
they want to have children.2 
Agree 
Disagree 
In my opinion, a woman can suggest 
using a condom just like a man can. 
Agree 
Disagree 
If a guy gets a woman pregnant, the 
child is the responsibility of both.2 
Agree 
Disagree 
A man and a woman should decide 













































 Percentages and chi-square score could not be calculated for these items as there was no comparison 
between agree and disagree because none of the respondents disagreed with these statements. 
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The first item in the section on sexual behavior responsibility asked participants to 
provide the level with which they agreed with the statement: "It is the man who decides 
what type of sex to have." A cross-tabulation and chi-square test was calculated between 
this item and the participants' willingness to vaccinate. The results of this cross-tab 
appear in Table 4. Of those participants who reported being willing to vaccinate against 
HPV approximately 60% agreed with this statement while 40% disagreed. For the 
participants who would not be willing to receive an HPV vaccine approximately 58% 
agreed with this statement while 42% disagreed. A chi-square test suggests that this 
relationship is not statistically significant. 
The fifth item in this section of the survey asked for agreement with the following 
statement: "In my opinion, a woman can suggest using a condom just like a man can." 
Again, a cross-tab was generated to exam the relationship between this item and 
willingness to vaccinate and the results can be found in Table 4. Of those who would be 
willing to vaccinate against the Human Papillomavirus approximately 95% agreed with 
this statement compared to 5% who disagreed. Of those who would not be willing to 
vaccinate against HPV approximately 96% agreed with this statement compared to 4% 
who disagreed. Again, a chi-square test of this relationship was not statistically 
significant. 
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Table 5. Chi-square of Perceived Risk for HPV and Willingness to Vaccinate 
Wil 
Perceived HPV Risk 
Men are just as likely to contract 




The medical complications of 
HPV are just as severe for men 
as they are for women. 
Agree 
Disagree 
HPV is the leading cause of 
penile and anal cancers in men. 
Agree 
Disagree 
It is just as important for men to 
protect themselves against HPV 

































Again, cross-tabulations and chi-square tests were conducted to examine the 
relationship between perceptions of risk for HPV and willingness to vaccinate against the 
virus. The results of these tests are presented in Table 5. None of the relationships 
between any of these four items and willingness to vaccinate were statistically 
significant. For example, the percentages for the cross-tabulation for agreement with item 
3, "HPV is the leading cause of penile and anal cancers in men," and respondents' 
willingness to vaccinate suggest that approximately 55% of those participants who would 
be willing to vaccinate against HPV agreed with this statement, while 45% who would be 
willing to vaccinate did not agree with this statement. The other three items in this section 
were not statistically related to willingness to vaccinate. 
Gardasil Campaign 
The end of the survey addressed a series of points regarding the current Merck 
Gardasil campaign. One question simply asked respondents how often in the last month 
they had seen or heard a commercial for Gardasil. Responses were given on a four point 
scale which ranges from 0-3 times, 4-6 times, 7-10 times, or 10 or more times. These 
responses were compared to respondents' willingness to receive an HPV vaccine in order 
to determine if there is a relationship between vaccine acceptance and exposure to the 
current Gardasil campaign. The results of this cross-tabulation and chi-square test appear 
in Table 6. 
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Table 6. Chi-square of Willingness to Vaccinate and Exposure to Gardasil Commercials 
Wil 
Exposure to Gardasil Commercials 




10 times or more 











Total (n) 42 26 
*p<.05 **p<.01 
The results in table 6 suggest that the number of times a participant has either 
seen or heard a Gardasil commercial does not have an effect on whether or not 
respondents would be willing to receive a Human Papillomavirus vaccine. There is not a 
large difference between the percentages of those who would be willing to vaccinate and 
whether they had seen or heard a Gardasil commercial 0-3 times in the past month or 4-6 
times in the past month. 
One open-ended response question asked respondent what they thought Gardasil 
was. In order to examine these responses, the answers were categorized and frequencies 
were tallied for each type. These results are presented in Table 7. 
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Table 7. Open-ended responses to Gardasil Campaign Questions 
Category of Response 
Respondent cannot define the 
word Gardasil 
Respondent identified Gardasil 
as a contraception for women 
Respondent identified Gardasil 
as a vaccine for women 
Respondent identified Gardasil 
as a cervical cancer prevention 
Respondent identified Gardasil 
















From Table 7 we can see that the majority of respondents, almost 41%, reported 
not knowing what Gardasil is at all. The next most frequent category was those 
respondents who knew that Gardasil is some type of HPV prevention. This does not mean 
respondents were necessarily aware that Gardasil is a vaccine but that they knew what it 
aimed to prevent. It should be noted that some respondents thought that Gardasil was a 
type of contraception for women (5.6%) and some that that it was purely a cervical 
cancer prevention tool (14.8%). The responses are interesting because they suggest an 
ambiguity in understanding about the current HPV vaccine. This ambiguousness could 
influence perceptions about the need for protection and the appropriateness of an HPV 
vaccine for men. 
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Summary 
Overall, none of the results of the analysis between sexual behavior responsibility 
or perception of risk for contracting the Human Papillomavirus and the medical 
complications associated with it are statistically related to college men's willingness to 
receive an HPV vaccine if one ever becomes available for them. None of the chi-square 
tests that were conducted examining agreement with the items on sexual behavior 
responsibility, respondents' age, relationship status, or willingness to vaccinate yielded 
statistically significant results. The same is true for the chi-square tests examining 
agreement with the items regarding perceived risk for HPV and respondents' age, 




Current medical research is aiming to establish a way to prevent high-risk strands 
of the Human Papillomavirus in men. HPV is the most commonly spread sexually 
transmitted infection in the United States and the cause of certain severe health problems, 
specifically, high rates of cervical cancer in women. Presently there is a vaccine that has 
been approved by the Federal Drug Administration for use in women that prevents for 
high-risk strands of HPV. In order to understand whether or not men would be willing to 
vaccinate themselves against the Human Papillomavirus it is important to investigate 
possible predictors of decision making and behavior. This acceptance study has aimed to 
look at two of these types of predictors, mainly, men's views on sexual behavior 
responsibility and decision making and their perceived risk for contracting the Human 
Papillomavirus and its medical complications. 
Hypothesis I 
The first hypothesis aimed to examine the relationship between men's perceptions 
of risk for contracting the Human Papillomavirus and their willingness to receive an HPV 
vaccine if one ever becomes available for men. In order to address this hypothesis, men 
were asked to provide their level of agreement with a series of statements on this topic 
and these responses were compared to their response to the willingness to vaccinate 
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question. In order to investigate this relationship I conducted chi-square tests with 
participants' agreement with each of these four items and their age, relationship status, 
and whether or not they would be willing to vaccinate against HPV. 
The first set of tests regarding perceived risk for HPV and respondents' age did 
not yield any statistically significant results. It does not appear that older participants are 
more informed about the Human Papillomavirus and their risk for contracting it 
compared to younger participants or vice versa. This could be due to the fact that there is 
not a very broad age range for participants. The age range was from 19 to 23 years old 
and this could not be wide enough to detect any real difference in perception of risk for 
HPV. Part of this could be the overall lack of knowledge among this age group. The 
Human Papillomavirus has only recently been brought to public attention with the 
creation and marketing of Gardasil so it could be that it is still widely unknown to young 
adults, especially young men who have not been the target of HPV prevention education 
so far. 
The second set of tests examined whether or not there was a relationship between 
perception of risk for HPV and respondents' relationship status. Again, it could be that 
there is an overall lack of knowledge, or confusion, regarding the Human Papillomavirus 
and men's risk for contracting the infection and this overall confusion exists regardless of 
whether or not men are in an exclusive relationship. It is surprising that there is not a 
difference between those respondents who report being single compared to those who 
report being in an exclusive relationship in regards to whether or not they feel it is 
necessary for men to protect themselves against HPV. It could be that responses to these 
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items were based on how responses feel about all men instead of making a judgment for 
themselves. 
The final set of statistical tests for this hypothesis examined the relationship 
between perception of risk and respondents' willingness to vaccinate themselves against 
HPV. It was hypothesized that the greater the level of perceived risk for HPV, the more 
likely respondents' would be to be willing to vaccinate against the virus. Again, this 
relationship was not statistically significant. Previous research found that one's level of 
knowledge about the Human Papillomavirus and related issues like cervical cancer did 
not affect the decision to vaccinate either one's self or one's child (Dempsey et al., 2006, 
Lenselink et al., 2007 and 2008). This could also be the case with this particular study. 
Perhaps individuals' willingness to vaccinate is based more on the suggestion of the 
medical field instead of what they know about particular diseases and preventions. 
Hypothesis II 
The second hypothesis investigated the relationship between respondents' level of 
sexual behavior responsibility and their willingness to vaccinate themselves against the 
Human Papillomavirus vaccine. In order to test this hypothesis I ran a number of 
statistical analyses comparing respondents' agreement with the seven sexual behavior 
responsibility items with their age, relationship status, and finally, with their reported 
willingness to vaccinate against the Human Papillomavirus. 
Initially, I investigated whether or not there was a relationship between 
participants' agreement with the items regarding sexual behavior responsibility and age. 
While none of the statistical analyses yielded significant results there were some patterns 
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in responses to some of the items. These patterns seem to suggest that younger 
respondents are more apt to think that men should make sexual behavior decisions 
without taking their partner's opinion into consideration. This could suggest a difference 
in level of maturity among respondents but again this relationship was not statistically 
significant so it is not possible to say that respondents' agreement with this statement is 
contingent on their age. 
I also looked at the relationship between agreement with the sexual behavior 
responsibility items and relationship status. Again while there were not any statistical 
significant relationships it seems that those who are committed to their sexual partner 
would not expect their partner to ask them to use protection, while those who are single 
or who are casually dating think it acceptable for their sexual partner to suggest using 
protection. It could be that participants in committed relationships do not feel that 
contraception and sexually transmitted infection protection is as necessary because they 
are only involved with one person. Another possible explanation could be that men who 
are involved in a committed relationship have already established what type of 
protection, if any, they would use to prevent unwanted pregnancy and to raise these 
questions with their partner again may seem unnecessary or even insulting. 
The final set of analyses which looked at respondents' agreement with the sexual 
behavior items and their willingness to vaccinate against HPV also did not result in any 
statistically significant relationships. It was hypothesized that men who felt that 
contraceptive use was a woman's responsibility would be less willing to vaccinate 
because a vaccine for a sexually transmitted infection would be viewed as another "safe 
sex" practice. One possible explanation is that the items used to address sexual behavior 
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responsibility do not deal with who men feel should be responsible for practicing safe sex 
but instead address men's attitudes towards sexual behavior. 
This lack of relationship is interesting when compared to previous research on 
similar topics, such as the work done by Oudshoorn (2003). Oudshoorn's book, The Male 
Pill, addressed the effect of male responsibility for family planning during the initial 
development of a male contraceptive pill. Oudshoorn (2003) suggested that in order for a 
male contraceptive pill to gain acceptance men would have to be included more in the 
larger area of family planning and be encouraged to be responsible for contraceptive use. 
The author sees this as one of the most important obstacles in overcoming the barriers to 
introduction and uptake of a male pill (Oudshoorn, 2003). It seems logical that this line of 
reasoning could be extended to prevention of sexually transmitted infections, especially 
those that, similar to unwanted pregnancies, affect women in more obvious ways than 
men. 
This study did not find a relationship between responsibility and acceptance that 
could be related to Oudshoorn's work. It could be that men do not view vaccinating 
against sexually transmitted infections in the same way that they view contraceptive use 
or other sexual behavior issues, like dealing with unplanned pregnancies. Perhaps there is 
a difference between vaccinating against the Human Papillomavirus and male 
contraceptive pills because the HPV vaccine for women has not been available long 
enough to have made a stereotypical impression on our views about protection and 
prevention. If the Gardasil vaccine for women remains the only HPV prevention tool then 
perhaps in the future there would be a difference in opinion about men's willingness to 
vaccinate themselves. It could be that, similar to a possible lack of knowledge 
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surrounding HPV, men also have not yet been socialized to believe that the HPV vaccine 
is purely a women's health issue. 
Another possible explanation could be that developments in areas like male 
contraception have made it easier for other new technologies, like sexually transmitted 
infection vaccines, to gain acceptance because there has already been some discussion 
surrounding male involvement in sexual behavior responsibility. It may be that the 
history of the male pill which Oudshoorn (2003) outlined in her book has affected the 
way college men view the Human Papillomavirus vaccine. It is difficult to tell if this is an 
issue surrounding time or if men's perceptions about vaccination are different then their 
views on sexual behavior responsibility and contraceptive use. 
Hypothesis III 
The third and final hypothesis for this study aimed to understand if there was any 
relationship between exposure to the current Gardasil campaign and willingness to 
vaccinate against the Human Papillomavirus vaccine. Statistical analyses of the items in 
the survey addressing exposure to the Gardasil campaign and knowledge about Gardasil 
with vaccine acceptance suggested that there is no statistically significant relationship 
between exposure to the campaign and acceptance. It could be that perhaps individuals 
may not pay much attention to the commercials they are viewing, especially if the 
characters featured are not of the same demographic characteristics. The Gardasil 
campaign has worked very hard to target mothers and girls and perhaps they are 
accomplishing their goal by attracting women and subsequently disregarding men. It 
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seems that despite the level of exposure to Gardasil or knowledge about the vaccine, the 
majority of college men are willing to vaccinate. 
The lack of statistical significance in these analyses could be due to the fact that 
the majority of college men, approximately 60% would be willing to receive an HPV 
vaccine and only 7% reported that they would be unwilling. It seems that regardless of 
how this sample feels about sexual behavior responsibility or what they believe about the 
Human Papillomavirus, they are willing to receive a vaccine. Could this be the result of a 
generation that has been raised to believe that vaccines, regardless of their risks or 
consequences, are a good thing? It may be due to the fact that because this generation has 
been receiving vaccines since birth that they do not question whether or not they should 
receive a particular vaccine. This willingness to vaccinate may be the result of a larger 
generational attitude towards vaccination instead of a gender specific attitude regarding 
sexual behavior responsibility and sexually transmitted infection prevention. 
Limitations 
There are several limitations to this study, most of which center around the 
methodology. These limitations are issues that should be addressed in future research in 
order to obtain a more accurate understanding of male HPV vaccine acceptance. The 
largest limitation in this study is the sample size and efforts should be made in the future 
to try and establish a larger, more representative sample. There was a difficulty in 
establishing both access to a male population for sampling and an actual sample of male 
participants. I think there is a specific difficulty in addressing this particular type of 
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population, male college students around twenty years old. As discussed earlier in the 
methods chapter, there may also be an effect of response bias because there may be 
something fundamentally different between those college men who chose to participate in 
this study compared to those who chose not to participate. While efforts were made to 
obtain participants with a raffle drawing incentive, it may have been easier to get 
participants if a larger incentive could have been provided. This was not possible for this 
study as there was not any grant or outside funding support. It may be necessary to obtain 
such support for a future study. 
As a result of this the small sample size, responses were collapsed for some items, 
most importantly the item which addressed participants' willingness to vaccinate. This is 
problematic because respondents who actually reported feeling neutral about the decision 
to vaccinate may actually not have thought about their willingness to vaccinate as much 
as those who made a decision either way. They also may not have as much knowledge 
about the Human Papillomavirus or the vaccine compared to those who reported being 
willing or unwilling to vaccinate or they may not be willing to vaccinate at the time this 
study was conducted but would be willing to vaccinate at some later time. Therefore, this 
may affect the results because the difference between the two groups may not be as 
apparent if the neutral responses were influencing the group which was considered 
"unwilling" to vaccinate. 
Another limitation to this study would be the extensiveness of the survey. I think 
it would be interesting for a future study to try and expand on the current survey and 
perhaps use scales to gain a level of sexual behavior responsibility or perceived risk. It 
may be helpful to compare participants based on levels of these categories instead of 
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having to look at each individual item in these categories as this study did. It may also be 
more beneficial to include more items under each of the sections of this survey to gain a 
better understanding of perceived risk and responsibility. Like other studies that have 
looked at different populations' acceptability (e.g., Dempsey et al., 2006, Lenselink et al., 
2008) it may also be helpful to include a measure of participants' level of knowledge 
about HPV and the vaccine and use an assessment that could rate how much they actually 
know about the infection and vaccine. Further ideas for future research in this area are 
presented in the next section. 
Future Research 
Vaccines for sexually transmitted infections are part of a rapidly expanding 
medical field and it is important to have research within the social sciences to accompany 
the medical field in order to understand the effects of one on the other. The Human 
Papillomavirus and its accompanying vaccine are undergoing great advancements right 
now and social science research should aim to keep up with the medical field. 
Specifically, while the Human Papillomavirus has previously been considered primarily a 
women's health issue, the medical field has begun to turn its attention towards men as 
research aims to create HPV tests for men and vaccines for male prevention. 
A future study may gain more insightful information by using in-depth interviews 
and focus groups to understand what men know about the Human Papillomavirus and 
how they feel they should be included in preventing against the infection and other 
sexually transmitted infections. The current study has really only provided an 
introduction to understanding the relationship between men's perceptions about risk and 
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responsibility and willingness to vaccinate. It is important that future research use larger 
statistical methods as well as mixed-methods approaches to gain further insight into male 
attitudes and beliefs that could affect behavior. Acceptability studies are important 
components to new medical technologies and future work in this area should aim to 
expand and deepen the understandings that this study has just begun to touch on. 
51 
REFERENCES 
Boehner, Constance W., Steven R. Howe, David I. Bernstein, and Susan L. Rosenthal. 
(2003). Viral Sexually Transmitted Disease Vaccine Acceptability Among College 
Students. Sexually Transmitted Diseases, 30(1): 774-778. 
Brabin, Loretta, Stephen A. Roberts, Farah Farzaneh and Henry C. Kitchener. (2006). 
Future acceptance of adolescent human papillomavirus vaccination: A survey of parental 
attitudes. Vaccine, 24: 3087- 3094. 
Centers for Disease Control and Prevention Fact Sheet: Genital HPV. (2008). [Online]. 
Available: http://www.cdc.gov/std/HPV/STDFact-HPV.htm. [2008, April 12]. 
Centers for Disease Control and Prevention, Vaccines and Immunizations: HPV Vaccine-
Questions & Answers for the Public. (2007). [Online]. Available: 
http://www.cdc.gov/vaccines/vpd-vac/hpv/hpv-vacsafe-effic.htm. [2008, April 12]. 
Dempsey, Amanda F., Gregory D. Zimet, Robert L. Davis and Laura Koutsky. (2006). 
Factors that are associated with parental acceptance of Human Papillomavirus vaccines: 
A randomized intervention study of written information about HPV. Pediatrics, 117: 
1486-1493. 
Goldstein, Mark A. (2008). Human Papillomavirus Vaccine in Males. New England 
Journal of Medicine, 359 (8): 863-864. 
Grady, William R., Koray Tanfer, John O.G. Billy, and Jennifer Lincoln-Hanson. (1996). 
Men's perceptions of their roles and responsibilities regarding sex, contraception and 
childrearing. Family Planning Perspectives, 28(5): 221-226. 
Jones, Melissa, and Robert Cook. (2008). Intent to receive and HPV vaccine among 
university men and women and implications for vaccine administration. Journal of 
American College Health, 57(1): 23-31. 
Lenselink, Charlotte H., Marloes M.J.G. Gerrits, Willem J.G. Melchers, Leon F.A.G. 
Massuger, Dennis van Hamont and Ruud L.M. Bekkers. (2008). Parental acceptance of 
Human Papillomavirus vaccines. European Journal of Obstetrics and Gynecology and 
Reproductive Biology, 137:103-107. 
Lenselink, C.H., C.E. Schmeink, W.J.G. Melchers, L.F.A.G. Massuger, J.C.M. Hendrik, 
D. Van Hamont, and R.L.M. Bekkers. (2008). Young adults and acceptance of the 
Human Papillomavirus vaccine. Public Health, 122(12): 1295-1301. 
52 
Marlow, Laura A.V., Jo Waller and Jane Wardle. (2007). Parental attitudes to pre-
pubertal HPV vaccination. Vaccine, 25: 1945-1952. 
Marshall, J. (1977). Acceptability of fertility regulating methods: Designing technology 
to fit people. Preventative Medicine, 6: 65-75. 
Oudshoorn, Nelly. (2003). The Male Pill. Duke University Press: Durham and London. 
Padian, N. S., Shiboski, S. C, and Jewell, N. P. (1991). Female-to-male transmission of 
human immunodeficiency virus. Journal of the American Medical Association, 266: 
1664-1667. 
Pulerwitz, Julie, and Gary Barker. (2007). Measuring attitudes toward gender norms 
among young men in Brazil: Development and psychometric evaluation of the GEM 






Dear Professor , 
My name is Angela Mitiguy and I am a second year Master's student in the 
Sociology Department. I am currently working on my Master's thesis and was hoping I 
could ask your assistance with my data collection. The purpose of my project is to 
investigate male college student's acceptance of a possible Human Papillomavirus 
vaccine for men. I am hoping to survey men here at UNH in regards to their beliefs about 
the HPV vaccine and their willingness to receive a vaccine. I would like to sample men 
who are enrolled in courses that could fulfill general education requirements for the 
college in order to get the broadest sample possible. In order to do this I am sampling 
students from courses that count towards UNH's general education requirements. Your 
class, , was chosen by random selection to participate in this 
study. 
I hope to collect my data as soon as possible. In order to do this I am hoping that 
you will be willing to provide your male students with an internet link to an online survey 
provided either via blackboard or during class. They could go to the website whenever 
they like and complete the survey in their own time. There would be a raffle incentive for 
those who choose to participate. 
My project has been approved by the IRB at UNH. If you have any further 
questions please feel free to contact me or my faculty advisor, Dr. Sharyn Potter in the 
Sociology Department at Sharyn.Potter@unh.edu. If you would be willing to help me in 
this endeavor, I ask that you please e-mail me back. If you choose to participate then I 
will be in further contact with you soon. Thank you so much for taking the time to read 








Title of Study: Male Attitudes Regarding Current Public Health Issues 
Principal Investigator: Angela Mitiguy, University of New Hampshire 
Purpose of Study: This study is designed to investigate male attitudes and beliefs about 
a public health issue. 
Procedure: You will be asked to complete a brief survey aimed at helping researchers 
understand men's attitudes towards a current public health issue. The survey should take 
you about 5 minutes to complete. 
Possible risks and benefits: A possible risk may be discomfort or anxiety that results 
from the sensitive nature of some of the questions. These are no direct benefits to the 
participant from participating in this study. 
Confidentiality of records: All records generated by this study will be confidential, to 
the extent possible when communicating via the internet. Paper records will only be 
available to researchers involved in this study. You will not be individually identified in 
any paper that may result from this project. 
Voluntary nature of participation: Participation in this study is completely voluntary 
and you may withdraw from participation at any point. You are free to refuse to answer 
any question in the survey. 
Request for more information: Please feel free to ask any questions you may have 
about this study. I will be happy to inform you of the results of the study when they are 
available. If you wish to speak with someone involved in this study regarding any 
problems or concerns you may have, contact the principal investigator, Angela Mitiguy at 
amx72@unh.edu. This study has been approved by the Institutional Review Board at the 
University of New Hampshire. If you have any questions about your rights as a research 
subject you can contact Julie Simpson in the UNH Office of Sponsored Research, 603-
862-2003 or Julie.simpson@unh.edu to discuss them. 
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I have read and I understand this consent form. Therefore, I agree to give my consent to 
participate as a subject in this research project. 
* 1. Please check the appropriate box: 
J I understand the above statements and wish to continue with the survey. 





1. How old are you in years? 
1.18 years old 
2. 19 years old 
3. 20 years old 
4. 21 years old 
5. 22 years old 
6. 23+ years old 
2. What is your college major? 
3. Which best describes your current marital status? 
1. Single 
2. Casually dating 
3. In a serious relationship 
4. Cohabiting with partner 
5. Married 




(1) Agree, (2) Partially Agree, (3) Do Not Agree 
1. It is the man who decides what type of sex to have. 
2. It is a woman's responsibility to avoid getting pregnant. 
3.1 would be outraged if my sexual partner asked me to use a condom. 
4. A couple should decide together if they want to have children. 
5. In my opinion, a woman can suggest using a condom just like a man can. 
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6. If a guy gets a woman pregnant, the child is the responsibility of both. 
7. A man and a woman should decide together what type of contraceptive to use. 
Risk: 
(1) Agree, (2) Partially Agree, (3) Do Not Agree 
1. Men are just as likely to contract the Human Papillomavirus as women. 
2. The medical complications of HPV are just as severe for men as they are for women. 
3. HPV is the leading cause of penile and anal cancers in men. 
4. It is just as important for men to protect themselves against HPV as it is for women. 
Exposure to HPV Vaccine Commercials: 
1. Can you tell me what Gardasil is? 
2. In the past month how many times have you seen or heard commercials for Gardasil? 
1. 0-3 times 
2. 4-6 times 
3. 7-10 times 
4. 10 or more times 
3. If you have seen any Gardasil commercials, can you list anything that you remember 
from the commercial? 
Willingness to receive an HPV vaccine: 
If one ever became available for men, how willing would you be to receive a Human 
Papillomavirus vaccine? Please disregard such issues as insurance coverage or cost. 
1. Very willing 
2. Somewhat willing 
3. Neither willing nor unwilling 
4. Somewhat unwilling 
5. Very unwilling 
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APPENDIX D 
RESOURCES FOR PARTICIPANTS 
We know that sexually transmitted infections and sexual behavior is a sensitive topic. 
After participating in this study, you might want to talk to someone for support and to 
gain more information. This is a list of organizations that are here to help you for any 
reason as well as a list of websites that provide information about the Human 
Papillomavirus and the current ways to prevent it. Again, you may also choose to contact 
the researcher as well. 
On Campus: 
UNH Counseling Center 862-2090 
UNH Health Services 862-1530 
Off Campus: 
Planned Parenthood (Portsmouth Health Center) 431-6803 
Wentworth Douglass Hospital 742-5252 
Human Papillomavirus Websites: 
Centers for Disease Control http://www.cdc.gov/std/hpv/default.htm 
Gardasil Vaccine www.gardasil.com 
Researcher: 
Angela Mitiguy amx72@unh.edu 
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APPENDIX E 
INSTITUTIONAL REVIEW BOARD APPROVAL FOR THE USE OF 
HUMAN SUBJECTS 
University of New Hampshire 
Research Conduct and Compliance Services, Office of Sponsored Research 




Sociology, Horton SSC 
16 Moon Brook Drive 
Rutland, VT 05701 
IRB # : 4460 
Study: The Effects of Perceived Risk and Responsibility on the Acceptance of a Human 
Papillomavirus Vaccine by College Men 
Approval Date: 13-Jan-2009 
The Institutional Review Board for the Protection of Human Subjects in Research (IRB) has 
reviewed and approved the protocol for your study as Exempt as described in Title 45, Code of 
Federal Regulations (CFR), Part 46, Subsection 101(b). Approval is granted to conduct your 
study as described in your protocol. 
Researchers who conduct studies involving human subjects have responsibilities as outlined in 
the attached document, Responsibilities of Directors of Research Studies Involving Human 
Subjects. (This document is also available at http://www.unh.edu/osr/compliance/irb.html.) 
Please read this document carefully before commencing your work involving human subjects. 
Upon completion of your study, please complete the enclosed Exempt Study Final Report form 
and return it to this office along with a report of your findings,*'* 
If you have questions or concerns about your study or this approval, please feel free to contact 
me at 603-862-2003 or Julie.simpson@unh.edu. Please refer to the IRB # above in all 
correspondence related to this study. The IRB wishes you success with your research. 
For the IRB, 
cc: File 
Potter, Sharyn 
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